| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 02/14/2013 | WO2013021971A1 Organic photoelectric conversion element and organic solar cell employing same |
| 02/14/2013 | US20130041158 Therapeutic agent and preventative agent for alzheimer's disease |
| 02/14/2013 | US20130041157 Therapeutic agent or preventive agent for urine collection disorder |
| 02/14/2013 | US20130041132 Chemical preparation of ubiquitin thioesters and modifications thereof |
| 02/14/2013 | US20130040999 New compounds for alleviation, prevention or treatment of osteoporosis, the preparation thereof and pharmaceutical composition comprising the same |
| 02/14/2013 | US20130040993 Fungicide hydroximoyl-heterocycles derivatives |
| 02/14/2013 | US20130040951 Prophylactic or therapeutic agent for cancer |
| 02/14/2013 | US20130039870 Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | CN102925139A Organic light-emitting material with excellent performance and preparation method thereof |
| 02/13/2013 | CN102924401A Dewatering method in production process of vulcanization promoter CZ |
| 02/13/2013 | CN102924400A N-acyl-4-tertiary butyl-5-benzyl thiazole-2-amine as well as preparation method and application thereof |
| 02/13/2013 | CN102924353A Febuxostat intermediate preparation method |
| 02/13/2013 | CN101296913B Heterocyclic amide derivatives useful as microbiocides |
| 02/13/2013 | CN101293874B Polyalcohol-filling material coupling additive agent |
| 02/12/2013 | US8372983 Ribonucleotide reductase inhibitors and methods of use |
| 02/12/2013 | US8372982 Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | CA2543054C Isopentylcarboxanilides for combating undesired micro-organisms |
| 02/07/2013 | WO2013019978A1 Fluorescence detection of cysteine and homocysteine |
| 02/07/2013 | WO2013018735A1 Amidine compound or salt thereof |
| 02/07/2013 | WO2013018095A1 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion |
| 02/07/2013 | WO2013017654A1 Novel estrogen receptor ligands |
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035332 Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2 |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | CA2843383A1 Amidine compound or salt thereof |
| 02/07/2013 | CA2842719A1 Novel estrogen receptor ligands |
| 02/06/2013 | EP2554541A1 Therapeutic agent or prophylactic agent for fibromyalgia |
| 02/06/2013 | EP2554540A2 3-Cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 02/06/2013 | CN1891697B Agents for preventing and controlling plant pests |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102917685A Cysteine derivative |
| 02/06/2013 | CN102911135A Synthetic method of 2-mercaptobenzothiazole derivative |
| 02/06/2013 | CN102911134A Synthesis process for cefditoren pivoxil intermediate |
| 02/06/2013 | CN101778834B Novel herbicides |
| 02/05/2013 | US8367843 Phenol derivative |
| 02/05/2013 | US8367842 Fluorescent dyes and uses thereof |
| 02/05/2013 | CA2547617C Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/31/2013 | WO2013016727A1 Cysteine prodrugs |
| 01/31/2013 | WO2013014205A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130030028 Desferrithiocin polyether analogues |
| 01/31/2013 | US20130030002 Fungicidal oximes and hydrazones |
| 01/31/2013 | CA2842106A1 Cysteine prodrugs |
| 01/31/2013 | CA2841911A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) - aminopropionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | CA2841905A1 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/30/2013 | EP2551266A1 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
| 01/30/2013 | CN102906077A Use of metformin in combination with glucokinase activator and compositions comprising metformin and glucokinase activator |
| 01/30/2013 | CN102898401A Novel preparation method of pramipexole |
| 01/30/2013 | CN102898400A GPR119 agonist and application thereof |
| 01/30/2013 | CN102898399A Method for preparing type II ritonavir polymouphous crystals |
| 01/30/2013 | CN102898398A Method for preparing type I ritonavir polymouphous crystals |
| 01/29/2013 | US8362267 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/29/2013 | US8362050 Compounds and methods for modulating G protein-coupled receptors |
| 01/29/2013 | US8362049 Urea glucokinase activators |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013010218A1 Inhibition of clathrin |
| 01/24/2013 | US20130023543 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023542 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023463 Hiv protease inhibiting compounds |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2547676A2 Modulators of hec1 activity and methods therefor |
| 01/23/2013 | EP2547667A1 Process for the production of 2-amino-5-fluorothiazole |
| 01/23/2013 | CN102892290A Noxious organism control agent |
| 01/22/2013 | US8357710 Bicyclic angiotensin II agonists |
| 01/22/2013 | US8357704 Fused heterocyclic compounds as inhibitors of potassium channel function |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/22/2013 | CA2527691C Condensed ring compound |
| 01/17/2013 | WO2012156998A3 Amorphous mirabegron and processes for crystal forms of mirabegron |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130017491 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same |
| 01/17/2013 | US20130017490 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same |
| 01/17/2013 | US20130017489 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same |
| 01/16/2013 | EP2546242A1 Cannabinoid receptor ligands |
| 01/16/2013 | EP2546241A1 Cannabinoid receptor ligands |
| 01/16/2013 | EP2545041A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 01/16/2013 | EP2544542A1 Analgesic compounds, compositions, and uses thereof |
| 01/16/2013 | CN102875273A Synthetic method of heteroaryl ether |
| 01/16/2013 | CN102040566B Intermediate for producing aminothiazole derivative |
| 01/15/2013 | US8354439 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 01/15/2013 | CA2693997C Viral polymerase inhibitors |
| 01/10/2013 | WO2013005153A1 Biaryl derivatives as nachr modulators |
| 01/10/2013 | WO2013004190A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof |
| 01/10/2013 | WO2013004075A1 Tumor targeted drug combretastatin a4 derivative |
| 01/10/2013 | US20130012719 Convenient Synthesis of Azolines to Azoles |
| 01/10/2013 | US20130012718 Purification method |
| 01/10/2013 | US20130012513 Hedgehog inhibitors |
| 01/10/2013 | US20130011787 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same |
| 01/10/2013 | CA2839942A1 Tumor-targeted drug combretastatin a4 derivatives |
| 01/09/2013 | EP2542541A1 Synthesis of chirally purified substituted benzothiazole diamines |
| 01/09/2013 | EP2542540A1 Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
| 01/09/2013 | EP2542081A1 Compounds for treatment of cancer |
| 01/09/2013 | CN102863402A Preparation method of accelerator CBS |
| 01/09/2013 | CN102863401A Novel process for producing medical intermediate DM (dibenzothiazyl disulfide) |
| 01/09/2013 | CN102863400A Refinement method of rubber vulcanization accelerator M |
| 01/09/2013 | CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative |
| 01/09/2013 | CN102861546A Stirring apparatus used in DM (dibenzothiazyl disulfide) synthesizing process |